yet these drugs are not a "home run," says elizabeth loder, md, a professor of neurology at harvard medical school and chief of the division of headache at brigham & women's hospital...
the software identified and measured a marker of svd and then gave a score indicating how severe the disease was ranging from mild to severe..

"we were quite surprised to find there were no significant differences," says study author.